The echo score revisited: Impact of incorporating commissural morphology and leaflet displacement to the prediction of outcome for patients undergoing percutaneous mitral valvuloplasty

Circulation

Volumn 129, Issue 8, 2014, Pages 886-895

  Nunes, Maria Carmo P ^a,b   Tan, Timothy C ^a   Elmariah, Sammy ^c   Do Lago, Rodrigo ^c   Margey, Ronan ^c   Cruz Gonzalez, Ignacio ^c   Zheng, Hui ^a   Handschumacher, Mark D ^a   Inglessis, Ignacio ^c   Palacios, Igor F ^c   Weyman, Arthur E ^a   Hung, Judy ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

balloon valvuloplasty; echocardiography; mitral valve stenosis

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIASTOLE; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; HIGH RISK POPULATION; HUMAN; LUNG PRESSURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME; VALIDATION STUDY;

BALLOON VALVULOPLASTY; ECHOCARDIOGRAPHY; MITRAL VALVE STENOSIS;

ADULT; AGED; AGED, 80 AND OVER; BALLOON VALVULOPLASTY; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE STENOSIS; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; YOUNG ADULT;

EID: 84896712944     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.001252     Document Type: Article

References (50)

1. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012;379:953-964.
2. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS. 2006 Writing Committee Members; American College of Cardiology/American Heart Association Task Force. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118:e523-e661.
3. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988;60:299-308.
4. Padial LR, Freitas N, Sagie A, Newell JB, Weyman AE, Levine RA, Palacios IF. Echocardiography can predict which patients will develop severe mitral regurgitation after percutaneous mitral valvulotomy. J Am Coll Cardiol. 1996;27:1225-1231.
5. Fatkin D, Roy P, Morgan JJ, Feneley MP. Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol. 1993;21:390-397.
6. Cannan CR, Nishimura RA, Reeder GS, Ilstrup DR, Larson DR, Holmes DR, Tajik AJ. Echocardiographic assessment of commissural calcium: a simple predictor of outcome after percutaneous mitral balloon valvotomy. J Am Coll Cardiol. 1997;29:175-180.
7. Sutaria N, Northridge DB, Shaw TR. Significance of commissural calcification on outcome of mitral balloon valvotomy. Heart. 2000;84:398-402.
8. Abascal VM, Wilkins GT, Choong CY, Block PC, Palacios IF, Weyman AE. Mitral regurgitation after percutaneous balloon mitral valvuloplasty in adults: evaluation by pulsed Doppler echocardiography. J Am Coll Cardiol. 1988;11:257-263.
9. Essop MR, Wisenbaugh T, Skoularigis J, Middlemost S, Sareli P. Mitral regurgitation following mitral balloon valvotomy. Differing mechanisms for severe versus mild-to-moderate lesions. Circulation. 1991;84:1669-1679.
10. Krishnamoorthy KM, Radhakrishnan S, Shrivastava S. Natural history and predictors of moderate mitral regurgitation following balloon mitral valvuloplasty using Inoue balloon. Int J Cardiol. 2003;87:31-36.
11. Feldman T, Carroll JD, Isner JM, Chisholm RJ, Holmes DR, Massumi A, Pichard AD, Herrmann HC, Stertzer SH, O'Neill WW. Effect of valve deformity on results and mitral regurgitation after Inoue balloon commissurotomy. Circulation. 1992;85:180-187.
12. Sanchez PL, Harrell LC, Salas RE, Palacios IF. Learning curve of the Inoue technique of percutaneous mitral balloon valvuloplasty. Am J Cardiol. 2001;88:662-667.
13. Padial LR, Abascal VM, Moreno PR, Weyman AE, Levine RA, Palacios IF. Echocardiography can predict the development of severe mitral regurgitation after percutaneous mitral valvuloplasty by the Inoue technique. Am J Cardiol. 1999;83:1210-1213.
14. Herrmann HC, Lima JA, Feldman T, Chisholm R, Isner J, O'Neill W, Ramaswamy K. Mechanisms and outcome of severe mitral regurgitation after Inoue balloon valvuloplasty. North American Inoue Balloon Investigators. J Am Coll Cardiol. 1993;22:783-789.
15. Elasfar AA, Elsokkary HF. Predictors of developing significant mitral regurgitation following percutaneous mitral commissurotomy with Inoue balloon technique. Cardiol Res Pract. 2011;2011:703515.
16. Abascal VM, Wilkins GT, O'Shea JP, Choong CY, Palacios IF, Thomas JD, Rosas E, Newell JB, Block PC, Weyman AE. Prediction of successful outcome in 130 patients undergoing percutaneous balloon mitral valvotomy. Circulation. 1990;82:448-456.
17. Reid CL, Chandraratna PA, Kawanishi DT, Kotlewski A, Rahimtoola SH. Influence of mitral valve morphology on double-balloon catheter balloon valvuloplasty in patients with mitral stenosis. Analysis of factors predicting immediate and 3-month results. Circulation. 1989;80:515-524.
18. Rifaie O, Esmat I, Abdel-Rahman M, Nammas W. Can a novel echocardiographic score better predict outcome after percutaneous balloon mitral valvuloplasty? Echocardiography. 2009;26:119-127.
19. Anwar AM, Attia WM, Nosir YF, Soliman OI, Mosad MA, Othman M, Geleijnse ML, El-Amin AM, Ten Cate FJ. Validation of a new score for the assessment of mitral stenosis using real-time three-dimensional echocardiography. J Am Soc Echocardiogr. 2010;23:13-22.
20. Abascal VM, Wilkins GT, Choong CY, Thomas JD, Palacios IF, Block PC, Weyman AE. Echocardiographic evaluation of mitral valve structure and function in patients followed for at least 6 months after percutaneous balloon mitral valvuloplasty. J Am Coll Cardiol. 1988;12:606-615.
21. Weyman AE. Principles and Practice of Echocardiography. Philadelphia, PA: Lea & Febiger; 1994.
22. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
23. Helmcke F, Nanda NC, Hsiung MC, Soto B, Adey CK, Goyal RG, Gatewood RP Jr. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 1987;75:175-183.
24. Hall SA, Brickner ME, Willett DL, Irani WN, Afridi I, Grayburn PA. Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta. Circulation. 1997;95:636-642.
25. Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I. Am Heart J. 1951;41:1-29.
26. Palacios I, Block PC, Brandi S, Blanco P, Casal H, Pulido JI, Munoz S, D'Empaire G, Ortega MA, Jacobs M. Percutaneous balloon valvotomy for patients with severe mitral stenosis. Circulation. 1987;75:778-784.
27. Palacios IF. What is the gold standard to measure mitral valve area postmitral balloon valvuloplasty? Cathet Cardiovasc Diagn. 1994;33:315-316.
28. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M; American Society of Echocardiography; European Association of Echocardiography. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22:1-23; quiz 101-102.
29. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
30. Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer; 2001.
31. Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York, NY: Springer; 2009.
32. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928-935.
33. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54:774-781.
34. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21:128-138.
35. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med. 1997;16:965-980.
36. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-172; discussion 207.
37. Pepe MS, Feng Z, Gu JW. Comments on 'evaluating the added predictive ability of a new marker: From area under the roc curve to reclassification and beyond' by Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Stat Med. 2008;27:173-181.
38. Reid CL, Otto CM, Davis KB, Labovitz A, Kisslo KB, McKay CR. Influence of mitral valve morphology on mitral balloon commissurotomy: immediate and six-month results from the NHLBI Balloon Valvuloplasty Registry. Am Heart J. 1992;124:657-665.
39. Kim MJ, Song JK, Song JM, Kang DH, Kim YH, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ. Long-term outcomes of significant mitral regurgitation after percutaneous mitral valvuloplasty. Circulation. 2006;114:2815-2822.
40. Iung B, Cormier B, Ducimetière P, Porte JM, Nallet O, Michel PL, Acar J, Vahanian A. Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. Circulation. 1996;94:2124-2130.
41. Korkmaz S, Demirkan B, Güray Y, Yilmaz MB, Aksu T, Saşmaz H. Acute and long-term follow-up results of percutaneous mitral balloon valvuloplasty: a single-center study. Anadolu Kardiyol Derg. 2011; 11:515-520.
42. Hernandez R, Macaya C, Bañuelos C, Alfonso F, Goicolea J, Iñiguez A, Fernandez-Ortiz A, Castillo J, Aragoncillo P, Gil Aguado M. Predictors, mechanisms and outcome of severe mitral regurgitation complicating percutaneous mitral valvotomy with the Inoue balloon. Am J Cardiol. 1992;70:1169-1174.
43. Bouleti C, Iung B, Laouénan C, Himbert D, Brochet E, Messika-Zeitoun D, Détaint D, Garbarz E, Cormier B, Michel PL, Mentré F, Vahanian A. Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients. Circulation. 2012;125:2119-2127.
44. Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block PC. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation. 2002;105:1465-1471.
45. Iung B, Garbarz E, Michaud P, Helou S, Farah B, Berdah P, Michel PL, Cormier B, Vahanian A. Late results of percutaneous mitral commissurotomy in a series of 1024 patients. Analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors. Circulation. 1999;99:3272-3278.
46. Fawzy ME, Hegazy H, Shoukri M, El Shaer F, ElDali A, Al-Amri M. Long-term clinical and echocardiographic results after successful mitral balloon valvotomy and predictors of long-term outcome. Eur Heart J. 2005;26:1647-1652.
47. Jneid H, Cruz-Gonzalez I, Sanchez-Ledesma M, Maree AO, Cubeddu RJ, Leon ML, Rengifo-Moreno P, Otero JP, Inglessis I, Sanchez PL, Palacios IF. Impact of pre- and postprocedural mitral regurgitation on outcomes after percutaneous mitral valvuloplasty for mitral stenosis. Am J Cardiol. 2009;104:1122-1127.
48. Hernandez R, Bañuelos C, Alfonso F, Goicolea J, Fernández-Ortiz A, Escaned J, Azcona L, Almeria C, Macaya C. Long-term clinical and echocardiographic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon. Circulation. 1999;99:1580-1586.
49. Song JK, Song JM, Kang DH, Yun SC, Park DW, Lee SW, Kim YH, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ. Restenosis and adverse clinical events after successful percutaneous mitral valvuloplasty: immediate postprocedural mitral valve area as an important prognosticator. Eur Heart J. 2009;30:1254-1262.
50. Cruz-Gonzalez I, Jneid H, Sanchez-Ledesma M, Cubeddu RJ, Martin- Moreiras J, Rengifo-Moreno P, Diaz TA, Kiernan TJ, Inglessis- Azuaje I, Maree AO, Sanchez PL, Palacios IF. Difference in outcome among women and men after percutaneous mitral valvuloplasty. Catheter Cardiovasc Interv. 2011;77:115-120.